Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on ...

STOUGHTON, Mass. - Collegium Pharmaceutical , Inc. (NASDAQ:COLL), a diversified biopharmaceutical company with a market capitalization of nearly $1 billion and impressive gross profit margins of 87%, ...

Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.

Yet, the cost of those innovations places new drugs out of reach for many patients and significantly burdens others. Are pharmaceutical companies earning too much? Deciding whether pharmaceutical ...

ELIO, Thermo Fisher Scientific is closer to its goal of powering its European sites with 100% renewable energy ...

BURLINGTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed ...

Agreement drives continued patient access to four important therapies in Japan and KoreaStrengthens Essential Pharma and Clinigen’s combined ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Most of these innovations have been done by smaller companies, and R&D efforts by the biggest pharmaceutical companies have often been not very successful. Nevertheless, the pharmaceutical industry is ...